Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma
Clinical trial NCT07545603 · RECRUITING
Trial details
- NCT number
- NCT07545603
- Sponsor
- Evopoint Biosciences Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-14
- Primary completion
- 2027-12-31
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.